Gut Journal

Overview

publication venue for

• To resect or not to resect? That is the question. Telangiectatic adenoma. 2010
• Cost-effectiveness of endoscopic, surgical and pharmacological obesity therapies: a microsimulation and threshold analyses. 2023
• Clinical, histological and molecular profiling of different stages of alcohol-related liver disease. 2022
• Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade..  71. 2021
• Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa..  70. 2020
• Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer..  69. 2020
• Plausibility criteria for putative pathophysiological mechanisms in functional gastrointestinal disorders: a consensus of experts..  67. 2017
• Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms..  66. 2016
• BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis..  66. 2016
• The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells..  64. 2015
• Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment..  64. 2015
• The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon..  65. 2015
• Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells..  63. 2014
• Exercise and associated dietary extremes impact on gut microbial diversity..  63. 2014
• Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C..  63. 2013
• HDGF-related protein-3 is required for anchorage-independent survival and chemoresistance in hepatocellular carcinomas..  62. 2012
• Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity..  62. 2012
• An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota..  61. 2011
• Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells..  61. 2011
• Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models..  59. 2010
• Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction..  59. 2010
• Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells..  58. 2009
• CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer..  58. 2008
• Rate and predictors of treatment prescription for hepatitis C..  56. 2006
• CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies..  55. 2006
• Activation of RegIIIbeta/gamma and interferon gamma expression in the intestinal tract of SCID mice: an innate response to bacterial colonisation of the gut..  54. 2005
• CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis..  54. 2005
• Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury..  54. 2005
• Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis..  54. 2005
• Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility..  52. 2003
• Imipramine decreases oesophageal pain perception in human male volunteers..  42. 1998
• Management of occluded biliary Wallstents..  42. 1998
• Epidemiological study of abdominal tuberculosis among Indian migrants and the indigenous population of Leicester, 1972-1989..  33. 1992
• Studies with the haeme oxygenase inhibitor Sn-protoporphyrin in patients with primary biliary cirrhosis and idiopathic haemochromatosis..  31. 1990
• Endoscopic sphincterotomy for common bile duct calculi in patients with gall bladder in situ considered unfit for surgery..  29. 1988
• Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer..  28. 1987
• Future requirements for colonoscopy in Britain. Report by the Endoscopy Section Committee of the British Society of Gastroenterology..  28. 1987
• Tumours and pseudotumours of the region of the ampulla of Vater: an endoscopic, clinical and pathological study..  27. 1986
• Detection of gall stones after acute pancreatitis..  26. 1985
• Endoscopic pancreatic and biliary manometry in pancreatic, biliary, and papillary disease, and after endoscopic sphincterotomy and surgical sphincteroplasty..  25. 1984
• Serum and pancreatic juice carcinoembryonic antigen in pancreatic and biliary disease..  21. 1980
• Gilbert's syndrome: evidence of morphological heterogeneity..  20. 1979
• Disinfection of upper gastrointestinal fibreoptic endoscopy equipment: an evaluation of a cetrimide chlorhexidine solution and glutaraldehyde..  19. 1978
• Stem cell-derived HCV infection systems illustrate the bright future of human hepatocyte research..  69. 2020
• A distinct subset of submucosal mast cells undergoes hyperplasia following neonatal maternal separation: a role in visceral hypersensitivity?.  58. 2009
• Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication..  55. 2006
• Can endoscopic papillary balloon dilation really preserve sphincter of Oddi function?.  49. 2001
• Primary polydipsia and autoimmune chronic active hepatitis..  29. 1988
• Radiology-guided percutaneous approach is superior to EUS for performing liver biopsies. 2021
• New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives. 2012
• The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. 2008
• Principles of applied neurogastroenterology: physiology/motility-sensation. 1999

Identity

ISO Abbreviation

• Gut

Linking ISSN

• 0017-5749

International Standard Serial Number (ISSN)

• 0017-5749

Electronic International Standard Serial Number (EISSN)

• 1468-3288